Kyverna Therapeutics (KYTX) Treasury Shares (2023 - 2026)

Kyverna Therapeutics (KYTX) has 4 years of Treasury Shares data on file, last reported at $24301.0 in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares fell 96.17% year-over-year to $24301.0; the trailing twelve-month figure through Mar 2026 stood at $24301.0 (down 96.17% YoY), and the FY2025 full-year result was $1.2 million, up 115.37% from the prior year.
• Treasury Shares for Q1 2026 stood at $24301.0, down from $1.2 million in the prior quarter.
• Across five years, Treasury Shares topped out at $1.3 million in Q3 2025 and bottomed at $8125.0 in Q4 2023.
• The 4-year median for Treasury Shares is $635167.0 (2025), against an average of $705661.6.
• The widest annual swing landed in 2024, when Treasury Shares surged 6656.94%; it then slumped 96.17% in 2026.
• A 4-year view of Treasury Shares shows it stood at $8125.0 in 2023, then soared by 6656.94% to $549001.0 in 2024, then jumped by 115.37% to $1.2 million in 2025, then tumbled by 97.94% to $24301.0 in 2026.
• The last three Treasury Shares figures came in at $24301.0 (Q1 2026), $1.2 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.

Peer Comparison